
Opinion|Videos|March 18, 2024
Complying with REMS Training and Documentation Requirements
Michael Singel, PharmD, discusses the logistics of complying with the Risk Evaluation and Mitigation Strategy program for bispecific antibodies at his institution and addresses training and documentation requirements.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FAQ: Guidance for Pharmacists, SSRIs Under Scrutiny and Political Debate
2
Atezolizumab Receives FDA Approvals for MIBC With Molecular Residual Disease
3
Q&A: Pharmacy Technicians and the Future of Obesity Management
4
How Clinical Pharmacists Optimize Obstructive Hypertrophic Cardiomyopathy Care
5





































































































































